|
|
| Year 2005 |
| Financials |
Claris closed year 2005 with revenues of Rs. 290 crores, recording a growth of 42% over year 2004.
|
CAGR (Compounded Annual Growth Rate) over last four years
– Sales : 44%
– EBIDTA : 42.5% |
| Product Registrations |
| Regulated Market |
Semi-Regulated Market |
| • |
6 ANDAs filed in USA |
• |
Product Registrations 210 |
| • |
Propofol successfully registered in
Australia & Singapore |
• |
Dossier submissions 723 |
| • |
1 product approved by MHRA,UK |
• |
2 Products registered in South Korea |
| • |
Dossier submissions made in several European countries including UK, Netherlands, France,Sweden, Finland |
• |
Ciprofloxacin, Metronidazole and
Hestar accepted as a 1st choice by
ASKES insurance company Indonesia |
|
| Manufacturing Facilities |
| • |
API manufacturing facility adhering to USFDA DMF guidelines commissioned. |
• |
Commissioning of Enteral Nutrition
Manufacturing Facilities |
| • |
Addition of SVP Line to Injectables
manufacturing Facility |
• |
Foundation laid for new manufacturing facility for bag manufacturing as well as expansion of current lines |
|
| Key Regulatory Approvals |
| Regulated Market |
Semi-Regulated Market |
| • |
MHRA - UK |
• |
GCC (Gulf Co-operative Council) |
| • |
TGA - Australia |
• |
ANVISA - Brazil |
| • |
NAM - Finland |
• |
SSA - Mexico |
| Inspections |
• |
INVIMA - Colombia |
| • |
MCC - South Africa |
• |
BPOM - Indonesia |
|
| Milestones |
| Regulated Market |
Semi-Regulated Market |
| • |
First supplies made to USA & Australia |
• |
First supplies made to China |
| • |
Out licensing agreement signed with leading German Hospital Supplies company |
• |
First Direct order from international Aid agency WHO |
| • |
Marketing & Distribution partners finalized for 4 European countries |
• |
Offices opened in China, Mexico & Indonesia |
| New Launches |
| • |
New Products launched... TetraHES, Cephalosporins range, Sucrofer, Envital |
| • |
Launch of Cardiology Division |
|
|
| No. of Products |
Manpower |
| • |
425 including variants |
• |
Total Team Strength 1600+ |
| • |
77 excluding variants |
|
|
| Global Brands |
| Brand Name |
No. of Countries |
| • |
Celemin
|
24 |
| • |
Celepid |
30 |
| • |
Cefo |
08 |
| • |
Ciprox |
27 |
| • |
Fluconazole |
19 |
| • |
Hestar |
27 |
| • |
I.V. Fluids |
17 |
| • |
Ketamine |
15 |
| • |
Metris |
33 |
| • |
Profol / Provive / Prosafe |
36 |
|
| Social |
| The prestigious “Claris International Critical Care Achievement Award” presented to Dr. Farookh E Udwadia |
|
|
|
